Scans that make prostate cancer cells ‘glow’ can eliminate the need for invasive biopsies—and they are already available in Australia and Europe.
The state of the art imaging test uses a molecule that binds to prostate cancer cells, causing them to “light up in a remarkable way”—appearing as bright spots in the scanning image.
The process could safely halve the number of men who need to undergo a biopsy for suspected prostate cancer following inconclusive results from an MRI scan, said the Australian scientists.
Their PSMA PET/CT scan identifies the more aggressive prostate cancer cells, which are potentially harmful and may need treatment—and could help reduce the risk of over-diagnosis by determining which cancers are low-risk and will never cause harm.
Read Full Article Here
